The Recall Desk
Severity pendingFDA (Drugs)·D-0036-2026·Announced 2025-10-29

KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)

Pending LLM rewrite. Source: FDA_DRUG D-0036-2026.

Severity not yet assessed

We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.

Plain-English summary

Presence of Particulate Matter: Particulate matter identified as glass

The recalled product

Product
KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
Brand
KETOROLAC TROMETHAMINE
Manufacturer
Aspiro Pharma Limited

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (9)

  • Lot #: AS1240347A
  • Exp Date 09/2026
  • AS1240144A
  • Exp Date 05/2026
  • AS1240145A
  • AS1240146A
  • Exp Date 06/2026
  • AS1250295A
  • Exp Date 05/2027.

Distribution

Distributed nationwide across the United States.